Received Jul 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received the first dose of Shingrix in 2018 but never received the second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Received 1st dose 2018). On an unknown date, the patient did not receive the 2nd dose of Shingrix. In 2018, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient received the first dose of Shingrix in 2018 but never received the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 25-JUN-2025 The healthcare professional reported a patient received the first dose of Shingrix in 2018 but never received the second dose. Till the time of reporting, the patient did not receive 2nd dose Shingrix vaccine which led to incomplete course of vaccination.